Table 2.
HPV VACCINE INITIATION | n | k | Effect Size | I2 | Difference | P | |
All studies | 1,751,281 | 94 | 0.0% [-1.8%,1.8%] | 98 | - | - | |
Correlate | |||||||
Publication Year | 2009–2010 | 557,222 | 25 | −3.0% [−6.4%,0.3%] | 92 | ref | - |
2012–2014 | 248,137 | 40 | −0.3% [−2.9%,2.4%] | 97 | 2.8% | 0.20 | |
2015–2017 | 945,922 | 29 | 2.9% [−0.1%,6.0%] | 97 | 6.0% | 0.01 | |
Sampling of Clusters | National | 1,430,561 | 60 | −0.2% [−2.5%,2.1%] | 98 | ref | - |
Regional/Single Site | 320,720 | 34 | 0.1% [−2.7%,2.9%] | 98 | 0.3% | 0.88 | |
Sampling of Individuals | Probability | 1,369,523 | 43 | 1.0% [−1.8%,3.8%] | 98 | ref | - |
Convenience | 381,758 | 51 | −0.8% [−3.1%, 1.5%] | 98 | −1.8% | 0.34 | |
Sex | Female | 922,842 | 80 | −1.6% [−3.5%,0.4%] | 97 | ref | - |
Male | 828,439 | 26 | 7.1% [3.9%,10.3%] | 99 | 8.7% | <.001 | |
Age Included (years) | Under 18 only | 1,201,965 | 35 | 4.3% [1.7%,6.9%] | 98 | ref | - |
Includes 18+ | 549,316 | 65 | −2.5% [−4.6%, −0.4%] | 97 | −6.8% | <.001 | |
Source of Race and Ethnicity Data | Self-Report | 448,820 | 79 | −1.3% [−3.2%,0.6%] | 97 | ref | - |
Administrative | 1,302,461 | 15 | 5.5% [1.5%,9.5%] | 99 | 6.8% | 0.003 | |
Source of Vaccination Data | Self-report | 264,260 | 64 | −3.6% [−5.5%, −1.7%] | 95 | ref | - |
Provider-verified | 1,487,021 | 30 | 6.0% [3.6%,8.5%] | 99 | 9.6% | <.001 | |
NIS—Teen Data | No | 1,604,353 | 85 | −1.1% [−2.9%,0.6%] | 98 | ref | - |
Yes | 146,928 | 9 | 7.9% [3.3%, 12.5%] | 98 | 9.0% | <.001 | |
HPV VACCINE FOLLOW-THROUGH | |||||||
All studies | 355,044 | 41 | −9.6% [−12.1%, −7.1%] | 96 | - | - | |
Correlate | |||||||
Publication Year | 2009–2010 | 169,326 | 12 | −15.1% [−18.9%, −11.2%] | 92 | ref | - |
2012–2014 | 42,228 | 12 | −6.6% [−10.8%, −2.5%] | 90 | 8.4% | 0.004 | |
2015–2017 | 143,490 | 17 | −6.5% [−10.0%, −3.0%] | 90 | 8.6% | 0.001 | |
Sampling of Clusters | National | 294,758 | 28 | −10.5% [−13.6%, −7.5%] | 97 | ref | - |
Regional/Single Site | 60,286 | 13 | −7.7% [−12.1%, −3.3%] | 93 | 2.8% | 0.30 | |
Sampling of Individuals | Probability | 291,971 | 26 | −9.7% [−13.0%, −6.5%] | 97 | ref | - |
Convenience | 63,073 | 15 | −9.4% [−13.5%, −5.4%] | 94 | 0.3% | 0.91 | |
Sex | Female | 259,774 | 39 | −9.4% [−11.9%, −6.8%] | 96 | ref | - |
Male | 95,270 | 10 | −5.7% [−10.9%, −0.6%] | 87 | 3.6% | 0.22 | |
Age Included (years) | Under 18 only | 163,432 | 16 | −8.0% [−11.8%, −4.2%] | 95 | ref | - |
Includes 18+ | 191,612 | 27 | −10.9% [−14.0%, −7.7%] | 95 | −2.9% | 0.25 | |
Source of Race and Ethnicity Data | Self-Report | 71,130 | 23 | −10.0% [−13.4%, −6.5%] | 93 | ref | - |
Administrative | 283,914 | 18 | −9.2% [−13.0%, −5.5%] | 98 | 0.8% | 0.77 | |
Source of Vaccination Data | Self-report | 7,817 | 9 | −13.7% [−19.3%, −8.1%] | 74 | ref | - |
Provider-verified | 347,227 | 32 | −8.6% [−11.4%, −5.9%] | 97 | 5.1% | 0.11 | |
NIS—Teen Data | No | 299,188 | 33 | −10.6% [−13.4%, −7.7%] | 96 | ref | - |
Yes | 55,856 | 8 | −6.3% [−11.5%, −1.2%] | 96 | 4.2% | 0.16 |
Note. Effect size is the difference in HPV vaccine initiation between minority and White. Negative numbers indicate a disparity, minorities had lower HPV vaccination coverage than Whites; positive numbers indicate a reverse disparity. NIS—Teen = National Immunization Survey—Teen.